PNC Financial Services Group
KIN

PNC Financial Services Group’s Kindred Biosciences, Inc. KIN Stock Holding History

PNC Financial Services Group’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-426
Closed -$4K – 4143
2019
Q4 		$4K Hold
426
– – ﹤0.01% 3714
2019
Q3 		$3K Buy
426
+409
+2,406% +$3K ﹤0.01% 3831
2019
Q2 		$0 Buy
+17
New +$147 ﹤0.01% 4204

Other funds holding KIN

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

PNC Financial Services Group's KIN Position: Q1 2020 in Review

PNC Financial Services Group sold out of Kindred Biosciences, Inc. (KIN) in Q1 2020, closing a stake of 426 shares — an estimated $4K sold.

PNC Financial Services Group first reported a position in KIN in Q2 2019 and held it in 3 quarters. The position peaked at $4K in Q4 2019. 77 funds tracked by Wall St. Rank hold KIN as of Q1 2020.

  • PNC Financial Services Group reported no remaining Kindred Biosciences, Inc. position as of Q1 2020 after selling out during the quarter.
  • PNC Financial Services Group sold 426 Kindred Biosciences, Inc. shares in Q1 2020, an estimated $4K.
  • PNC Financial Services Group first reported a position in Kindred Biosciences, Inc. in Q2 2019 and held it in 3 quarters.
  • PNC Financial Services Group's Kindred Biosciences, Inc. position peaked at $4K in Q4 2019.
  • 77 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q1 2020.

Based on PNC Financial Services Group's 13F filing for Q1 2020, filed 8 May 2020.